- Home
- MDGL vs GIB Comparison
MDGL vs GIB Comparison
Compare MDGL & GIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | GIB |
|---|---|---|
| Founded | 2011 | 1976 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 14.3B |
| IPO Year | 2005 | 1999 |
Fundamental Metrics
Financial Performance| Metric | MDGL | GIB |
|---|---|---|
| Price | $497.82 | $64.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 3 |
| Target Price | ★ $674.45 | $112.00 |
| AVG Volume (30 Days) | 254.7K | ★ 483.3K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | ★ 41.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $58.39 | $8.33 |
| Revenue Next Year | $48.55 | $2.96 |
| P/E Ratio | ★ N/A | $13.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $265.00 | $61.91 |
| 52 Week High | $615.00 | $110.07 |
Technical Indicators
Market Signals| Indicator | MDGL | GIB |
|---|---|---|
| Relative Strength Index (RSI) | 44.46 | 30.63 |
| Support Level | $461.99 | $61.91 |
| Resistance Level | $502.97 | $75.34 |
| Average True Range (ATR) | 20.67 | 2.68 |
| MACD | -4.06 | -0.53 |
| Stochastic Oscillator | 12.36 | 15.05 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.